Patients Views & Analysis

Views & Analysis

Patients

Authentication by facial recognition concept. Biometric. Security system.

The ‘patient of the future’ is driving radical innovation in...

Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of a new healthcare landscape, says Debiopharm Innovation Fu

Patients

Addressing the HIV epidemic in Eastern Europe and Central As...

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences.

Patients

It’s time to do better for patients with rare neurological d...

Global Gene’s Craig Martin introduces a new patient identification initiative that strives to improve diagnosis and access to clinical trials for all patients with rare CNS conditions.

Patients

Taking stock of NHS medicines optimisation

Given the rising cost of medicines as a share of the NHS budget in England, the establishment of ICSs provides a timely opportunity to take stock on delivering medicines optimisation at loc

Patients

Professor Nigel Osbourne on medical music

Prof Nigel Osborne: Science is catching up with ‘medical mus...

The internationally recognised composer, peace worker and musical therapy pioneer tells pharmaphorum how his emerging field stands at an important threshold

Patients

Close up view of a dedicated worker carrying a stack of duck taped brown boxes in factory storage room while wearing sterile cloths and rubber gloves.

Improving access to treatments in challenging markets

The COVID-19 pandemic has highlighted the importance of ensuring a reliable supply of treatments across the globe at pace and speed. Jirair Ratevosian, executive director of global patient

The ‘patient of the future’ is driving radical innovation in...

Addressing the HIV epidemic in Eastern Europe and Central As...

It’s time to do better for patients with rare neurological d...

Taking stock of NHS medicines optimisation

Prof Nigel Osborne: Science is catching up with ‘medical mus...

Improving access to treatments in challenging markets

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks